News & Announcements Archive

Search Our Archives

Pharma, under attack for drug prices, started an industry war

With national and state advertising campaigns, white papers and cartoon infographics, the powerful and well-funded drug industry lobby spent 2017 working to redirect public anger about drug prices to pharmacy benefits managers (or PBMs): links in the supply chain that sits invisibly between the patient and the drug maker — in the process bringing a […]

Lawmakers zero in on next target in fight against high drug prices

Both Republican and Democratic senators have criticized moves by drug makers to extend the life of their monopolies on sales. But action on high drug prices, a major concern for consumers, has been so far negligible in this Congress. Gerry Anderson is quoted.